Rose Merc Intrinsic Value
Rose Merc intrinsic value. Rose Merc (ROSEMER) median intrinsic value is ₹83.46 from 9 valuation models (range ₹11–₹113), vs current price ₹37.73 — +121.2% upside (Trading Below Calculated Value), margin of safety 54.8%. For current market price and key ratios, visit ROSEMER share price.
ROSEMER Valuation Methods Summary — DCF, Graham Number & P/E
Rose Merc intrinsic value across 9 models vs current price ₹37.73 — upside/downside and value range per method. Read ROSEMER dividend track record for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹113.19 | ₹90.55 - ₹135.83 | +200.0% | EPS: ₹13.04, Sector P/E: 12x |
| Book Value Method | asset | ₹94.32 | ₹84.89 - ₹103.75 | +150.0% | Book Value/Share: ₹146.67, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹75.46 | ₹67.91 - ₹83.01 | +100.0% | Revenue/Share: ₹186.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹75.46 | ₹67.91 - ₹83.01 | +100.0% | EBITDA: ₹20.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹83.46 | ₹75.11 - ₹91.81 | +121.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹107.45 | ₹96.70 - ₹118.20 | +184.8% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹75.46 | ₹67.91 - ₹83.01 | +100.0% | ROE: 22.7%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹113.19 | ₹101.87 - ₹124.51 | +200.0% | EPS: ₹13.04, BVPS: ₹146.67 |
| Dividend Yield Method | dividend | ₹11.32 | ₹10.19 - ₹12.45 | -70.0% | DPS: ₹0.35, Target Yield: 3.5% |
ROSEMER Intrinsic Value vs Market Price — All Valuation Models
Rose Merc fair value range ₹11–₹113 vs current market price ₹37.73 across 9 valuation models. Compare with Rose Merc valuation methods to assess whether the stock is under or overvalued.
ROSEMER Intrinsic Value Analysis — Undervalued or Overvalued?
Rose Merc median intrinsic value ₹83.46, current price ₹37.73 — Trading Below Calculated Value by 121.2%, margin of safety 54.8%.
What is the intrinsic value of ROSEMER?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Rose Merc (ROSEMER) is ₹83.46 (median value). With the current market price of ₹37.73, this represents a +121.2% variance from our estimated fair value.
The valuation range spans from ₹11.32 to ₹113.19, indicating ₹11.32 - ₹113.19.
Is ROSEMER undervalued or overvalued?
Based on our multi-method analysis, Rose Merc (ROSEMER) appears to be trading below calculated value by approximately 121.2%.
ROSEMER Financial Health — Key Ratios vs Industry Benchmarks
Rose Merc financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 25.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 22.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.15x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ROSEMER Cash Flow Quality — Operating & Free Cash Flow
Rose Merc operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹11 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹-3 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-8 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |